Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics company Invitae has partnered with BioMarin, Stoke Therapeutics, and Xenon Pharmaceuticals to expand its free genetic testing program for children with epilepsy.

The Behind the Seizure program previously provided no-cost genetic testing for children ages two to four who had an unprovoked seizure. Invitae and its partners are now making free testing under this program available to children from birth up to five years old.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.